Auxilium holders may convert 1.5% notes into Endo shares after merger

By Susanna Moon

Chicago, Jan. 29 – Auxilium Pharmaceuticals, Inc.’s 1.5% convertible senior notes due 2018 are now convertible into cash and ordinary shares of Endo International plc.

Endo closed the acquisition of Auxilium on Thursday, triggering the change, according to 8-K filing with the Securities and Exchange Commission.

As a result, for each share of Auxilium common stock a holder of notes was previously entitled to receive upon conversion of the notes, the holder will instead receive $9.88 in cash and 0.343 of an Endo share.

In addition, under the supplemental indenture, Endo became a co-obligor of Auxilium’s obligations under the notes.

Endo is a Dublin-based specialty health care company that has U.S. headquarters in Malvern, Pa. Auxilium is a Chesterbrook, Pa.-based specialty biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.